Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × irinotecan sucrosofate × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Pancreatic Adenocarcinoma 1 Metastatic Adenocarcinoma of the Pancreas 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡